rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1997-4-22
|
pubmed:abstractText |
Membrane-type-1 matrix metalloproteinase has been identified as an activator of the matrix metalloproteinase progelatinase A at cell surfaces. We report here that a soluble active form of membrane-type-2 matrix metalloproteinase can also process progelatinase A in a comparable fashion to the type-1 at rates which are dependent on the concentration of the proenzyme. Activation is inhibited by tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3, but only partially by TIMP-1. These results suggest that cellular activation of progelatinase A may be initiated by different members of the membrane-type matrix metalloproteinase family depending on tissue distribution.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Precursors,
http://linkedlifedata.com/resource/pubmed/chemical/Gelatinases,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinases...,
http://linkedlifedata.com/resource/pubmed/chemical/Metalloendopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/progelatinase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0014-2956
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
244
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
653-7
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:9119036-Amino Acid Sequence,
pubmed-meshheading:9119036-Base Sequence,
pubmed-meshheading:9119036-Binding Sites,
pubmed-meshheading:9119036-DNA Primers,
pubmed-meshheading:9119036-Enzyme Activation,
pubmed-meshheading:9119036-Enzyme Precursors,
pubmed-meshheading:9119036-Escherichia coli,
pubmed-meshheading:9119036-Gelatinases,
pubmed-meshheading:9119036-Glycoproteins,
pubmed-meshheading:9119036-Humans,
pubmed-meshheading:9119036-Kinetics,
pubmed-meshheading:9119036-Matrix Metalloproteinases, Membrane-Associated,
pubmed-meshheading:9119036-Metalloendopeptidases,
pubmed-meshheading:9119036-Protease Inhibitors,
pubmed-meshheading:9119036-Protein Processing, Post-Translational,
pubmed-meshheading:9119036-Proteins,
pubmed-meshheading:9119036-Recombinant Proteins,
pubmed-meshheading:9119036-Tissue Inhibitor of Metalloproteinase-2,
pubmed-meshheading:9119036-Tissue Inhibitor of Metalloproteinase-3,
pubmed-meshheading:9119036-Tissue Inhibitor of Metalloproteinases
|
pubmed:year |
1997
|
pubmed:articleTitle |
Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
|
pubmed:affiliation |
Strangeways Research Laboratory, Cambridge, UK.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|